The miR-561-5p/CX3CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX3CR1+ Natural Killer Cells Infiltration

Natural killer (NK) cell can inhibit tumor initiation and regulates metastatic dissemination, acting as key mediators of the innate immune response. Intrinsic factors modulating NK cells infiltration and its anticancer activity remain poorly characterized. We investigated the roles of dysregulation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Theranostics 2019-01, Vol.9 (16), p.4779-4794
Hauptverfasser: Er-Bao, Chen, Zheng-Jun, Zhou, Xiao, Kun, Gui-Qi, Zhu, Yang, Yi, Wang, Biao, Shao-Lai, Zhou, Chen, Qing, Yin, Dan, Wang, Zheng, Ying-Hong, Shi, Dong-Mei, Gao, Chen, Jie, Zhao, Yan, Wei-Zhong, Wu, Fan, Jia, Zhou, Jian, Dai, Zhi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4794
container_issue 16
container_start_page 4779
container_title Theranostics
container_volume 9
creator Er-Bao, Chen
Zheng-Jun, Zhou
Xiao, Kun
Gui-Qi, Zhu
Yang, Yi
Wang, Biao
Shao-Lai, Zhou
Chen, Qing
Yin, Dan
Wang, Zheng
Ying-Hong, Shi
Dong-Mei, Gao
Chen, Jie
Zhao, Yan
Wei-Zhong, Wu
Fan, Jia
Zhou, Jian
Dai, Zhi
description Natural killer (NK) cell can inhibit tumor initiation and regulates metastatic dissemination, acting as key mediators of the innate immune response. Intrinsic factors modulating NK cells infiltration and its anticancer activity remain poorly characterized. We investigated the roles of dysregulation of micro(mi)RNAs and NK cells in progression of hepatocellular carcinoma (HCC). Methods: Small RNA sequencing were used to detect the miRNA profiles of tumor tissues from HCC patients with (n=14) or without (n=13) pulmonary metastasis and HCC cell lines with different pulmonary metastatic potentials. Chemokine expression profiling and bioinformatics were used to detect the downstream target of candidate target. In gain- and loss-of-function assays were used to investigate the role of miRNA in HCC progression. Different subsets of NK cells were isolated and used for chemotaxis and functional assays in vivo and in vitro. In situ hybridization and immunohistochemical analyses were performed to detect the expression of miRNA in tumor tissues from 242 HCC patients undergoing curative resection from 2010. Results: Three miRNAs (miR-137, miR-149-5p, and miR-561-5p) were identified to be associated with pulmonary metastasis in patients with HCC. miR-561-5p was most highly overexpressed in metastatic HCC tissues and high-metastatic-potential HCC cell lines. In gain- and loss-of-function assays in a murine model, miR-561-5p promoted tumor growth and spread to the lungs. Yet, miR-561-5p did not appear to affect cellular proliferation and migration in vitro. Bioinformatics and chemokine expression profiling identified chemokine (C-X3-C motif) ligand 1 (CX3CL1) as a potential target of miR-561-5p. Furthermore, miR-561-5p promoted tumorigenesis and metastasis via CX3CL1-dependent regulation of CX3CR1+ NK cell infiltration and function. CX3CR1+ NK cells demonstrated stronger in vivo anti-metastatic activity relative to CX3CR1- NK cells. CX3CL1 stimulated chemotactic migration and cytotoxicity in CX3CR1+ NK cells via STAT3 signaling. Blockade of CX3CL1, CX3CR1, or of pSTAT3 signaling pathways attenuated the antitumor responses. Clinical samples exhibited a negative correlation between miR-561-5p expression and levels of CX3CL1 and CX3CR1+ NK cells. High miR-561-5p abundance, low CX3CL1 levels, and low numbers of CX3CR1+ NK cells were associated with adverse prognosis. Conclusion: We delineated a miR-561-5p/CX3CL1/NK cell axis that drives HCC metastasis and demonstrated that CX3
doi_str_mv 10.7150/thno.32543
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6643446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2267751342</sourcerecordid><originalsourceid>FETCH-LOGICAL-j373t-1f3f6e8d79488f99e57c7b26d557ecf4ef005141dd5487f59dbd11871f7b21de3</originalsourceid><addsrcrecordid>eNpdkM1q3DAQgEUgJCHZS59A0EuhOLGsX18KwaTd0G0StinkZrT2aFeLLG0seUmeIy9cLc0lHQbmMN98zAxCn0h5KQkvr9LGh0tacUaP0BlRVBVSsPIUzWLcljlYWdWkPkGnlFAhKy7P0NvjBvBglwUXpOC7q-aJNguCf9u11876Nb5-sREvYT05nSDih8kNwevxFf-CpGPO3LYez2GnU-jAuQyOuNFjZ30YNL71--D2B9NBvSRf8Z1O06gd_mmdg4zmmZgxY10adbLBX6Bjo12E2Xs9R3--3zw282Jx_-O2uV4UWyppKoihRoDqZc2UMnUNXHZyVYmecwmdYWDKkhNG-p4zJQ2v-1VPiJLEZIr0QM_Rt3_e3bQaoO_A5wVcuxvtkA9sg7btx463m3Yd9q0QjDImsuDLu2AMzxPE1A42Hn6gPYQptlUlpOSEsiqjn_9Dt2Ea848zxWtViVpSRf8CkoCMtQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2598269738</pqid></control><display><type>article</type><title>The miR-561-5p/CX3CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX3CR1+ Natural Killer Cells Infiltration</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Er-Bao, Chen ; Zheng-Jun, Zhou ; Xiao, Kun ; Gui-Qi, Zhu ; Yang, Yi ; Wang, Biao ; Shao-Lai, Zhou ; Chen, Qing ; Yin, Dan ; Wang, Zheng ; Ying-Hong, Shi ; Dong-Mei, Gao ; Chen, Jie ; Zhao, Yan ; Wei-Zhong, Wu ; Fan, Jia ; Zhou, Jian ; Dai, Zhi</creator><creatorcontrib>Er-Bao, Chen ; Zheng-Jun, Zhou ; Xiao, Kun ; Gui-Qi, Zhu ; Yang, Yi ; Wang, Biao ; Shao-Lai, Zhou ; Chen, Qing ; Yin, Dan ; Wang, Zheng ; Ying-Hong, Shi ; Dong-Mei, Gao ; Chen, Jie ; Zhao, Yan ; Wei-Zhong, Wu ; Fan, Jia ; Zhou, Jian ; Dai, Zhi</creatorcontrib><description>Natural killer (NK) cell can inhibit tumor initiation and regulates metastatic dissemination, acting as key mediators of the innate immune response. Intrinsic factors modulating NK cells infiltration and its anticancer activity remain poorly characterized. We investigated the roles of dysregulation of micro(mi)RNAs and NK cells in progression of hepatocellular carcinoma (HCC). Methods: Small RNA sequencing were used to detect the miRNA profiles of tumor tissues from HCC patients with (n=14) or without (n=13) pulmonary metastasis and HCC cell lines with different pulmonary metastatic potentials. Chemokine expression profiling and bioinformatics were used to detect the downstream target of candidate target. In gain- and loss-of-function assays were used to investigate the role of miRNA in HCC progression. Different subsets of NK cells were isolated and used for chemotaxis and functional assays in vivo and in vitro. In situ hybridization and immunohistochemical analyses were performed to detect the expression of miRNA in tumor tissues from 242 HCC patients undergoing curative resection from 2010. Results: Three miRNAs (miR-137, miR-149-5p, and miR-561-5p) were identified to be associated with pulmonary metastasis in patients with HCC. miR-561-5p was most highly overexpressed in metastatic HCC tissues and high-metastatic-potential HCC cell lines. In gain- and loss-of-function assays in a murine model, miR-561-5p promoted tumor growth and spread to the lungs. Yet, miR-561-5p did not appear to affect cellular proliferation and migration in vitro. Bioinformatics and chemokine expression profiling identified chemokine (C-X3-C motif) ligand 1 (CX3CL1) as a potential target of miR-561-5p. Furthermore, miR-561-5p promoted tumorigenesis and metastasis via CX3CL1-dependent regulation of CX3CR1+ NK cell infiltration and function. CX3CR1+ NK cells demonstrated stronger in vivo anti-metastatic activity relative to CX3CR1- NK cells. CX3CL1 stimulated chemotactic migration and cytotoxicity in CX3CR1+ NK cells via STAT3 signaling. Blockade of CX3CL1, CX3CR1, or of pSTAT3 signaling pathways attenuated the antitumor responses. Clinical samples exhibited a negative correlation between miR-561-5p expression and levels of CX3CL1 and CX3CR1+ NK cells. High miR-561-5p abundance, low CX3CL1 levels, and low numbers of CX3CR1+ NK cells were associated with adverse prognosis. Conclusion: We delineated a miR-561-5p/CX3CL1/NK cell axis that drives HCC metastasis and demonstrated that CX3CR1+ NK cells serve as potent antitumor therapeutic effectors.</description><identifier>EISSN: 1838-7640</identifier><identifier>DOI: 10.7150/thno.32543</identifier><identifier>PMID: 31367257</identifier><language>eng</language><publisher>Wyoming: Ivyspring International Publisher Pty Ltd</publisher><subject>Cell growth ; Chemokines ; Gene expression ; Human subjects ; Laboratory animals ; Liver cancer ; Lung cancer ; Medical prognosis ; Metastasis ; MicroRNAs ; Research Paper ; Surgery ; Tumors</subject><ispartof>Theranostics, 2019-01, Vol.9 (16), p.4779-4794</ispartof><rights>2019. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The author(s) 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643446/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643446/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Er-Bao, Chen</creatorcontrib><creatorcontrib>Zheng-Jun, Zhou</creatorcontrib><creatorcontrib>Xiao, Kun</creatorcontrib><creatorcontrib>Gui-Qi, Zhu</creatorcontrib><creatorcontrib>Yang, Yi</creatorcontrib><creatorcontrib>Wang, Biao</creatorcontrib><creatorcontrib>Shao-Lai, Zhou</creatorcontrib><creatorcontrib>Chen, Qing</creatorcontrib><creatorcontrib>Yin, Dan</creatorcontrib><creatorcontrib>Wang, Zheng</creatorcontrib><creatorcontrib>Ying-Hong, Shi</creatorcontrib><creatorcontrib>Dong-Mei, Gao</creatorcontrib><creatorcontrib>Chen, Jie</creatorcontrib><creatorcontrib>Zhao, Yan</creatorcontrib><creatorcontrib>Wei-Zhong, Wu</creatorcontrib><creatorcontrib>Fan, Jia</creatorcontrib><creatorcontrib>Zhou, Jian</creatorcontrib><creatorcontrib>Dai, Zhi</creatorcontrib><title>The miR-561-5p/CX3CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX3CR1+ Natural Killer Cells Infiltration</title><title>Theranostics</title><description>Natural killer (NK) cell can inhibit tumor initiation and regulates metastatic dissemination, acting as key mediators of the innate immune response. Intrinsic factors modulating NK cells infiltration and its anticancer activity remain poorly characterized. We investigated the roles of dysregulation of micro(mi)RNAs and NK cells in progression of hepatocellular carcinoma (HCC). Methods: Small RNA sequencing were used to detect the miRNA profiles of tumor tissues from HCC patients with (n=14) or without (n=13) pulmonary metastasis and HCC cell lines with different pulmonary metastatic potentials. Chemokine expression profiling and bioinformatics were used to detect the downstream target of candidate target. In gain- and loss-of-function assays were used to investigate the role of miRNA in HCC progression. Different subsets of NK cells were isolated and used for chemotaxis and functional assays in vivo and in vitro. In situ hybridization and immunohistochemical analyses were performed to detect the expression of miRNA in tumor tissues from 242 HCC patients undergoing curative resection from 2010. Results: Three miRNAs (miR-137, miR-149-5p, and miR-561-5p) were identified to be associated with pulmonary metastasis in patients with HCC. miR-561-5p was most highly overexpressed in metastatic HCC tissues and high-metastatic-potential HCC cell lines. In gain- and loss-of-function assays in a murine model, miR-561-5p promoted tumor growth and spread to the lungs. Yet, miR-561-5p did not appear to affect cellular proliferation and migration in vitro. Bioinformatics and chemokine expression profiling identified chemokine (C-X3-C motif) ligand 1 (CX3CL1) as a potential target of miR-561-5p. Furthermore, miR-561-5p promoted tumorigenesis and metastasis via CX3CL1-dependent regulation of CX3CR1+ NK cell infiltration and function. CX3CR1+ NK cells demonstrated stronger in vivo anti-metastatic activity relative to CX3CR1- NK cells. CX3CL1 stimulated chemotactic migration and cytotoxicity in CX3CR1+ NK cells via STAT3 signaling. Blockade of CX3CL1, CX3CR1, or of pSTAT3 signaling pathways attenuated the antitumor responses. Clinical samples exhibited a negative correlation between miR-561-5p expression and levels of CX3CL1 and CX3CR1+ NK cells. High miR-561-5p abundance, low CX3CL1 levels, and low numbers of CX3CR1+ NK cells were associated with adverse prognosis. Conclusion: We delineated a miR-561-5p/CX3CL1/NK cell axis that drives HCC metastasis and demonstrated that CX3CR1+ NK cells serve as potent antitumor therapeutic effectors.</description><subject>Cell growth</subject><subject>Chemokines</subject><subject>Gene expression</subject><subject>Human subjects</subject><subject>Laboratory animals</subject><subject>Liver cancer</subject><subject>Lung cancer</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>MicroRNAs</subject><subject>Research Paper</subject><subject>Surgery</subject><subject>Tumors</subject><issn>1838-7640</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkM1q3DAQgEUgJCHZS59A0EuhOLGsX18KwaTd0G0StinkZrT2aFeLLG0seUmeIy9cLc0lHQbmMN98zAxCn0h5KQkvr9LGh0tacUaP0BlRVBVSsPIUzWLcljlYWdWkPkGnlFAhKy7P0NvjBvBglwUXpOC7q-aJNguCf9u11876Nb5-sREvYT05nSDih8kNwevxFf-CpGPO3LYez2GnU-jAuQyOuNFjZ30YNL71--D2B9NBvSRf8Z1O06gd_mmdg4zmmZgxY10adbLBX6Bjo12E2Xs9R3--3zw282Jx_-O2uV4UWyppKoihRoDqZc2UMnUNXHZyVYmecwmdYWDKkhNG-p4zJQ2v-1VPiJLEZIr0QM_Rt3_e3bQaoO_A5wVcuxvtkA9sg7btx463m3Yd9q0QjDImsuDLu2AMzxPE1A42Hn6gPYQptlUlpOSEsiqjn_9Dt2Ea848zxWtViVpSRf8CkoCMtQ</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Er-Bao, Chen</creator><creator>Zheng-Jun, Zhou</creator><creator>Xiao, Kun</creator><creator>Gui-Qi, Zhu</creator><creator>Yang, Yi</creator><creator>Wang, Biao</creator><creator>Shao-Lai, Zhou</creator><creator>Chen, Qing</creator><creator>Yin, Dan</creator><creator>Wang, Zheng</creator><creator>Ying-Hong, Shi</creator><creator>Dong-Mei, Gao</creator><creator>Chen, Jie</creator><creator>Zhao, Yan</creator><creator>Wei-Zhong, Wu</creator><creator>Fan, Jia</creator><creator>Zhou, Jian</creator><creator>Dai, Zhi</creator><general>Ivyspring International Publisher Pty Ltd</general><general>Ivyspring International Publisher</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190101</creationdate><title>The miR-561-5p/CX3CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX3CR1+ Natural Killer Cells Infiltration</title><author>Er-Bao, Chen ; Zheng-Jun, Zhou ; Xiao, Kun ; Gui-Qi, Zhu ; Yang, Yi ; Wang, Biao ; Shao-Lai, Zhou ; Chen, Qing ; Yin, Dan ; Wang, Zheng ; Ying-Hong, Shi ; Dong-Mei, Gao ; Chen, Jie ; Zhao, Yan ; Wei-Zhong, Wu ; Fan, Jia ; Zhou, Jian ; Dai, Zhi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j373t-1f3f6e8d79488f99e57c7b26d557ecf4ef005141dd5487f59dbd11871f7b21de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Cell growth</topic><topic>Chemokines</topic><topic>Gene expression</topic><topic>Human subjects</topic><topic>Laboratory animals</topic><topic>Liver cancer</topic><topic>Lung cancer</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>MicroRNAs</topic><topic>Research Paper</topic><topic>Surgery</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Er-Bao, Chen</creatorcontrib><creatorcontrib>Zheng-Jun, Zhou</creatorcontrib><creatorcontrib>Xiao, Kun</creatorcontrib><creatorcontrib>Gui-Qi, Zhu</creatorcontrib><creatorcontrib>Yang, Yi</creatorcontrib><creatorcontrib>Wang, Biao</creatorcontrib><creatorcontrib>Shao-Lai, Zhou</creatorcontrib><creatorcontrib>Chen, Qing</creatorcontrib><creatorcontrib>Yin, Dan</creatorcontrib><creatorcontrib>Wang, Zheng</creatorcontrib><creatorcontrib>Ying-Hong, Shi</creatorcontrib><creatorcontrib>Dong-Mei, Gao</creatorcontrib><creatorcontrib>Chen, Jie</creatorcontrib><creatorcontrib>Zhao, Yan</creatorcontrib><creatorcontrib>Wei-Zhong, Wu</creatorcontrib><creatorcontrib>Fan, Jia</creatorcontrib><creatorcontrib>Zhou, Jian</creatorcontrib><creatorcontrib>Dai, Zhi</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Theranostics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Er-Bao, Chen</au><au>Zheng-Jun, Zhou</au><au>Xiao, Kun</au><au>Gui-Qi, Zhu</au><au>Yang, Yi</au><au>Wang, Biao</au><au>Shao-Lai, Zhou</au><au>Chen, Qing</au><au>Yin, Dan</au><au>Wang, Zheng</au><au>Ying-Hong, Shi</au><au>Dong-Mei, Gao</au><au>Chen, Jie</au><au>Zhao, Yan</au><au>Wei-Zhong, Wu</au><au>Fan, Jia</au><au>Zhou, Jian</au><au>Dai, Zhi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The miR-561-5p/CX3CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX3CR1+ Natural Killer Cells Infiltration</atitle><jtitle>Theranostics</jtitle><date>2019-01-01</date><risdate>2019</risdate><volume>9</volume><issue>16</issue><spage>4779</spage><epage>4794</epage><pages>4779-4794</pages><eissn>1838-7640</eissn><abstract>Natural killer (NK) cell can inhibit tumor initiation and regulates metastatic dissemination, acting as key mediators of the innate immune response. Intrinsic factors modulating NK cells infiltration and its anticancer activity remain poorly characterized. We investigated the roles of dysregulation of micro(mi)RNAs and NK cells in progression of hepatocellular carcinoma (HCC). Methods: Small RNA sequencing were used to detect the miRNA profiles of tumor tissues from HCC patients with (n=14) or without (n=13) pulmonary metastasis and HCC cell lines with different pulmonary metastatic potentials. Chemokine expression profiling and bioinformatics were used to detect the downstream target of candidate target. In gain- and loss-of-function assays were used to investigate the role of miRNA in HCC progression. Different subsets of NK cells were isolated and used for chemotaxis and functional assays in vivo and in vitro. In situ hybridization and immunohistochemical analyses were performed to detect the expression of miRNA in tumor tissues from 242 HCC patients undergoing curative resection from 2010. Results: Three miRNAs (miR-137, miR-149-5p, and miR-561-5p) were identified to be associated with pulmonary metastasis in patients with HCC. miR-561-5p was most highly overexpressed in metastatic HCC tissues and high-metastatic-potential HCC cell lines. In gain- and loss-of-function assays in a murine model, miR-561-5p promoted tumor growth and spread to the lungs. Yet, miR-561-5p did not appear to affect cellular proliferation and migration in vitro. Bioinformatics and chemokine expression profiling identified chemokine (C-X3-C motif) ligand 1 (CX3CL1) as a potential target of miR-561-5p. Furthermore, miR-561-5p promoted tumorigenesis and metastasis via CX3CL1-dependent regulation of CX3CR1+ NK cell infiltration and function. CX3CR1+ NK cells demonstrated stronger in vivo anti-metastatic activity relative to CX3CR1- NK cells. CX3CL1 stimulated chemotactic migration and cytotoxicity in CX3CR1+ NK cells via STAT3 signaling. Blockade of CX3CL1, CX3CR1, or of pSTAT3 signaling pathways attenuated the antitumor responses. Clinical samples exhibited a negative correlation between miR-561-5p expression and levels of CX3CL1 and CX3CR1+ NK cells. High miR-561-5p abundance, low CX3CL1 levels, and low numbers of CX3CR1+ NK cells were associated with adverse prognosis. Conclusion: We delineated a miR-561-5p/CX3CL1/NK cell axis that drives HCC metastasis and demonstrated that CX3CR1+ NK cells serve as potent antitumor therapeutic effectors.</abstract><cop>Wyoming</cop><pub>Ivyspring International Publisher Pty Ltd</pub><pmid>31367257</pmid><doi>10.7150/thno.32543</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1838-7640
ispartof Theranostics, 2019-01, Vol.9 (16), p.4779-4794
issn 1838-7640
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6643446
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Cell growth
Chemokines
Gene expression
Human subjects
Laboratory animals
Liver cancer
Lung cancer
Medical prognosis
Metastasis
MicroRNAs
Research Paper
Surgery
Tumors
title The miR-561-5p/CX3CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX3CR1+ Natural Killer Cells Infiltration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T08%3A28%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20miR-561-5p/CX3CL1%20Signaling%20Axis%20Regulates%20Pulmonary%20Metastasis%20in%20Hepatocellular%20Carcinoma%20Involving%20CX3CR1+%20Natural%20Killer%20Cells%20Infiltration&rft.jtitle=Theranostics&rft.au=Er-Bao,%20Chen&rft.date=2019-01-01&rft.volume=9&rft.issue=16&rft.spage=4779&rft.epage=4794&rft.pages=4779-4794&rft.eissn=1838-7640&rft_id=info:doi/10.7150/thno.32543&rft_dat=%3Cproquest_pubme%3E2267751342%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2598269738&rft_id=info:pmid/31367257&rfr_iscdi=true